Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Odyssey Therapeutics, Inc. | 11,111 | reported | 11 May 2026 | tx 1+11,111 |
| HilleVax, Inc. | 0 | reported | 17 Sept 2025 | tx 5+87,199−17,199 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | PURCHASE | Odyssey Therapeutics, Inc. | 11,111 | 18.00 USD | |
| 17 Sept 2025 | TENDER | HilleVax, Inc. | 17,199 | — | |
| 23 Jun 2025 | GRANT_AWARD | HilleVax, Inc. | 17,199 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | HilleVax, Inc. | 22,500 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | HilleVax, Inc. | 22,500 | 0.00 USD | deriv |
| 19 Aug 2022 | GRANT_AWARD | HilleVax, Inc. | 25,000 | 0.00 USD | deriv |